Posted in Antibodies, Assay Kits, cDNA, Clia Kits, Culture Cells, Devices, DNA, DNA Templates, DNA Testing, Elisa Kits, PCR, Peptides, Reagents, Recombinant Proteins, Ria Kits, RNA, Test Kits
Combined Placental Maternal Floor Infarction and Cytomegalovirus Placentitis: A Case Report
Mother’s infarction (MFI) and Masif Fibrin Perive (MPFD) deposition (MPFD) are unusual, related to the condition of the secondary placenta of trophoblastic cell damage. The etiology is unknown but MPFD / MFI is associated with adverse obstetric results and a significant risk of repeatment. Case Report: We report the MPFD / MFI case related to placentitis Cytomegalovirus (CMV). A 27-year-old mother gave birth to a man’s fetus born with a postmortem diagnosis of default CMV.
The placenta shows limfohistiocial villitis with isolated CMV inclusion, in combination with MFI. Villitis has an intermediary feature between unclean cmv placentitis and ethiological villitis (Vue). Conclusion: Vue is considered a reaction of an anti-fetal immune mother who resembles the refusal of allograft. We postulate that viral infections in our case may have triggered this immune response, considering that CMV antigens are known to be crossing with some human antigens, especially HLA. The next trophoblastic cell damage can then lead to MFI / MFPD.
Hemolytic uremic syndrome and atypical nephrotic syndrome associated with cytomegalovirus infection
Atypical hemolytic uremic syndrome (ahus) is a rare disease. It is produced from the disregulation of alternative complementary pathways on the cell surface which causes endothelial damage. Increasing evidence evidence, this disorder is for mutations in the complementary regulator gene or with autoantibodies to complementary factors. This mutation has incomplete penetration and variable phenotypes.
Cytomegalovirus (CMV) is endemic throughout the world, and the incidence of severe CMV disease in immunocompetent adults seems to be greater than previously thought. Ahus and nephrotic syndrome associated with CMV infection rarely occur. The identification of triggers for the manifestation of the ahus in patients who are vulnerable genetics is very important because this allows faster clinical treatment and improvement initiations. We reported a case of a man with the removal of homozygous CFHR3-1 whose initial presentation was ahus and nephrotic syndrome associated with CMV infection.
IgA binds epitop glycoprotein B and neutralizes human cytomegalovirus
Human Cytomegalovirus (HCMV) is a pathogen everywhere that has the potential for pathogens in immunosuppression individuals and pregnant women during primary infections. HCMV Envelope Glycoprotein B (GB) facilitates virus entries into all types of cells and induces strong immune responses. Epitope AD-2 is a very preserved GB Linear GB epitope and the critical target for antibodies, only 50% of seropositive individuals that make IgG antibodies to this site and the rib response has not been fully investigated.
This study aims to compare IGG and IGA responses to GB and Epitop AD-2 in individuals who are exposed to naturally and those who receive the recombinant Ajuvant GB / MF59 vaccine. Thus, seropositive individual vaccination increases the existing IGA and GB IGG levels and induces the rib response and specific IGG de Novo GB on seronegative receivers. The existing IgG response and AD-2 ribs were driven by vaccination but the response of De Novo AD-2 was not detected. Individuals exposed naturally have the dominant IgG response to GB and AD-2 compared to weaker rib responses and variables, although significant rib response to AD-2 was observed in the ASI ASI sample.
All antibodies tie the AD-2 contain a light chain of kappa while the use of a balanced capa / lambda light chain is found for those who bind to GB. The V-region matches the specific recombinant IGG AD-2 and ribs are bound to GB and AD-2 and neutralize HCMV infection in vitro. Overall, this result shows that even though the human IGG response dominates, class IGA antibodies against AD-2 are significant components of breast milk that can function to protect neonates from HCMV.
Cytomegalovirus After a kidney transplant in 2020: moving towards personalized prevention
Cytomegalovirus (CMV) – Close complications after kidney transplants remain a substantial challenge. Instead of applying a preventive strategy to all risky patients, we can now adjust our strategies at the individual patient level. The prophylaxis of antivirus or strict pre-emptive strategies may be optimal for patients with the highest risk for CMV, while lower risk patients can be profitable especially from pre-emptive monitoring and therapeutic administration only if needed.
CMV Special T-Testing may be useful to improve the determination of CMV risk in pre-transplants, and to guide decisions about the need for antivirus therapy or duration. Immunosupressive regimens including the target of the Rapamycin mammal inhibitor reduces the risk of CMV and thus can be an interesting choice in some patients. The new antivirus agent further expanded our therapy arsenal in the near future, and the prospect of CMV vaccination and remove cell therapy seems to be on the horizon.

Cytomegalovirus Pre-Transplant Immunity and Risk of Viral Reactivation After Lung Transplantation: Prospective Cohort Study
Cytomegalovirus (CMV) remains a significant burden on the recipient of the lung transplant. Disadvantages in the immunity of the TP-transplant increases the risk of complications related to CMV. However, it is not clear if the underlying pre-transplant immunity increases risk. To assess this, we recruit 39 lung transplant patients and do quantiferon-CMV in their peripheral blood. More than a third of prospective cmv-seropositive transplant receivers are non-imun-reactive CMV (CMV-NIR) pre-transplant.
SARS-CoV-2 Spike S1 RBD Protein, Mouse Fc-fusion |
E80026 |
EpiGentek |
|
|
SARS-CoV-2 Spike S1 (16-685) Protein, Avi-His-tag |
E80021 |
EpiGentek |
|
|
SARS-CoV-2 Spike S1 RBD (V367F) Protein, Avi-His-tag |
E80023 |
EpiGentek |
|
|
SARS-CoV-2 Spike S1 (13-665) Protein, Fc Fusion, Avi-tag |
E80020 |
EpiGentek |
|
|
SARS-CoV-2 Spike S1 (16-685) Protein, Fc Fusion, Avi-tag |
E80022 |
EpiGentek |
|
|
SARS-CoV-2 Spike S1 RBD Protein, Human Fc-Fusion, Avi-Tag |
E80025 |
EpiGentek |
|
|
Recombinant Transmembrane Protease Serine 2 Protein, Partial |
E80016 |
EpiGentek |
-
EUR 470.80
-
EUR 753.50
-
EUR 1824.90
|
|
HBA Polyclonal Antibody |
ABP58750-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of HBA from Human, Mouse, Rat. This HBA antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human HBA protein at amino acid sequence of 30-110 |
HBA Polyclonal Antibody |
ABP58750-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of HBA from Human, Mouse, Rat. This HBA antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human HBA protein at amino acid sequence of 30-110 |
HBA Polyclonal Antibody |
ABP58750-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of HBA from Human, Mouse, Rat. This HBA antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human HBA protein at amino acid sequence of 30-110 |
HBA Polyclonal Antibody |
ES11261-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
Description: A Rabbit Polyclonal antibody against HBA from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
HBA Polyclonal Antibody |
ES11261-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
Description: A Rabbit Polyclonal antibody against HBA from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Anti-HBA antibody |
STJ192419 |
St John's Laboratory |
200 µl |
EUR 236.4 |
Description: Unconjugated Rabbit polyclonal to HBA |
Hba Polyclonal Antibody |
A53679-020 |
EpiGentek |
20 ul |
Ask for price |
Hba Polyclonal Antibody |
A53679-050 |
EpiGentek |
50 ul |
Ask for price |
Hba Polyclonal Antibody |
A53679-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Hba Polyclonal Antibody |
A53679 |
EpiGentek |
-
EUR 684.66
-
Ask for price
-
Ask for price
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
Hba Antibody, HRP conjugated |
1-CSB-PA010147LB01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Hba. Recognizes Hba from Mouse. This antibody is HRP conjugated. Tested in the following application: ELISA |
Hba Antibody, FITC conjugated |
1-CSB-PA010147LC01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Hba. Recognizes Hba from Mouse. This antibody is FITC conjugated. Tested in the following application: ELISA |
Hba Antibody, Biotin conjugated |
1-CSB-PA010147LD01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Hba. Recognizes Hba from Mouse. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Human Brain Astrocytes (HBA) |
HMP202 |
Neuromics |
500,000+ cells - Frozen |
EUR 1296 |
Hba-a2 sgRNA CRISPR Lentivector (Rat) (Target 2) |
K6915803 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Hba-a2 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3179403 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Hba-x sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3266403 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Hba-a1 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K3332403 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Hemoglobin Subunit Alpha (Hba) Antibody |
20-abx109857 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Mouse Hemoglobin subunit alpha (Hba) |
1-CSB-EP010147MO |
Cusabio |
-
EUR 606.00
-
EUR 318.00
-
EUR 2192.40
-
EUR 919.20
-
EUR 1461.60
-
EUR 402.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mouse Hemoglobin subunit alpha(Hba) expressed in E.coli |
Mouse Hemoglobin subunit alpha (Hba) |
1-CSB-YP010147MO |
Cusabio |
-
EUR 604.80
-
EUR 318.00
-
EUR 2198.40
-
EUR 915.60
-
EUR 1459.20
-
EUR 400.80
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mouse Hemoglobin subunit alpha(Hba) expressed in Yeast |
HBA ELISA Kit (Mouse) (OKEH05810) |
OKEH05810 |
Aviva Systems Biology |
96 Wells |
EUR 794.4 |
Description: Description of target: Involved in oxygen transport from the lung to the various peripheral tissues. ;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.84 ng/mL |
HBA ELISA Kit (Bovine) (OKEH03848) |
OKEH03848 |
Aviva Systems Biology |
96 Wells |
EUR 934.8 |
Description: Description of target: Involved in oxygen transport from the lung to the various peripheral tissues.;Species reactivity: Bovine;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.59 ng/mL |
Hba-a2 Recombinant Protein (Rat) |
RP204248 |
ABM |
100 ug |
Ask for price |
Hba-a1 Recombinant Protein (Mouse) |
RP140990 |
ABM |
100 ug |
Ask for price |
Hba-a2 Recombinant Protein (Mouse) |
RP140993 |
ABM |
100 ug |
Ask for price |
Hba-x Recombinant Protein (Mouse) |
RP140996 |
ABM |
100 ug |
Ask for price |
Hba Polyclonal Antibody, HRP Conjugated |
A53680-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Hba Polyclonal Antibody, HRP Conjugated |
A53680-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Hba Polyclonal Antibody, FITC Conjugated |
A53681-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Hba Polyclonal Antibody, FITC Conjugated |
A53681-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Hba Polyclonal Antibody, Biotin Conjugated |
A53682-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Hba Polyclonal Antibody, Biotin Conjugated |
A53682-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Hba Polyclonal Antibody, HRP Conjugated |
A53680 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Hba Polyclonal Antibody, FITC Conjugated |
A53681 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Hba Polyclonal Antibody, Biotin Conjugated |
A53682 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Rat Hemoglobin subunit alpha-1/2, HBA ELISA Kit |
ELA-E0517r |
Lifescience Market |
96 Tests |
EUR 1063.2 |
Human Anti-Influenza B virus IgA ELISA kit, 96 tests, Quantitative |
920-410-HBA |
Alpha Diagnostics |
1 Kit |
EUR 854.4 |
Hba-a2 ORF Vector (Rat) (pORF) |
ORF068084 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Hba-a1 ORF Vector (Mouse) (pORF) |
ORF046998 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Hba-a2 ORF Vector (Mouse) (pORF) |
ORF046999 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Hba-x ORF Vector (Mouse) (pORF) |
ORF047000 |
ABM |
1.0 ug DNA |
EUR 607.2 |
Recombinant TMPRSS2 Protein, Partial |
E80017 |
EpiGentek |
-
EUR 423.50
-
EUR 660.00
-
EUR 2321.00
|
|
Recombinant Novel Coronavirus Spike Glycoprotein(S), Partial |
E80018 |
EpiGentek |
-
EUR 388.30
-
EUR 860.20
-
EUR 4888.40
|
|
Nori® Human Angiopoietin-2 (ANG-2) ELISA Kit (2 plates) |
GR106245-2 |
Genorise Scientific |
2 x 96-well |
EUR 998.4 |
Nori Equine MMP-2/TIMP-2 Complex ELISA Kit (2 plates) |
GR106502-2 |
Genorise Scientific |
2 x 96-well |
EUR 998.4 |
2-Propyl-β-D-glucuronide, 2 mg |
0904-2 |
AthenaES |
2 mg |
EUR 194.4 |
Bovine HBA/ Hemoglobin subunit alpha ELISA Kit |
E0304Bo |
Sunlong |
1 Kit |
EUR 860.4 |
Hba-a2 sgRNA CRISPR Lentivector set (Rat) |
K6915801 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Human Hemoglobin subunit alpha, HBA ELISA Kit |
ELA-E05171h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Bovine Hemoglobin subunit alpha, HBA ELISA Kit |
ELA-E0517b |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Chicken Hemoglobin subunit alpha, HBA ELISA Kit |
ELA-E0517c |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Canine Hemoglobin subunit alpha, HBA ELISA Kit |
ELA-E0517d |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Mouse Hemoglobin subunit alpha, HBA ELISA Kit |
ELA-E0517m |
Lifescience Market |
96 Tests |
EUR 1038 |
Porcine Hemoglobin subunit alpha, HBA ELISA Kit |
ELA-E0517p |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Hba-a2 sgRNA CRISPR Lentivector set (Mouse) |
K3179401 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Hba-x sgRNA CRISPR Lentivector set (Mouse) |
K3266401 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Hba-a1 sgRNA CRISPR Lentivector set (Mouse) |
K3332401 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Nori® Human MMP-2/TIMP-2 Complex ELISA Kit (2 plates) |
GR106372-2 |
Genorise Scientific |
2 x 96-well |
EUR 998.4 |
Nori® Human b-defensin 2 (BD-2) ELISA Kit- 2 Plates |
GR111099-2 |
Genorise Scientific |
2 x 96-well |
EUR 998.4 |
Hba-a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
K6915807 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Hba-a2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K3179407 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Hba-x sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K3266407 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Hba-a1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K3332407 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Nori® Chicken Netrin-2 ELISA Kit (2 plates) |
GR106184-2 |
Genorise Scientific |
2 x 96-well |
EUR 998.4 |
Nori® Human Trappin-2 ELISA Kit (2 plates) |
GR106467-2 |
Genorise Scientific |
2 x 96-well |
EUR 998.4 |
IL-2 Interleukin-2 Human Recombinant Protein, His Tag |
PROTP60568-2 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: Interleukin-2 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 133 amino acids fragment (21-153) having a molecular weight of 20kDa and fused with a 4.5kDa amino-terminal hexahistidine tag. _x000D_ The IL-2 His is purified by proprietary chromatographic techniques._x000D_ |
Nori® Canine (dog) IL-2 ELISA Kit (2 plates) |
GR106163-2 |
Genorise Scientific |
2 x 96-well |
EUR 998.4 |
Nori® Porcine (pig) IL-2 ELISA Kit (2 plates) |
GR106188-2 |
Genorise Scientific |
2 x 96-well |
EUR 998.4 |
Nori® Porcine b-defensin 2 ELISA Kit- 2 Plates |
GR113081-2 |
Genorise Scientific |
2 x 96-well |
EUR 998.4 |
BMP-2 Bone Morphogenetic Protein-2 Human Recombinant Protein, Monomer |
PROTP12643-2 |
BosterBio |
Regular: 20ug |
EUR 380.4 |
Description: Bone Morphogenetic Protein-2 Human Recombinant produced in E.Coli is a monomeric, non-glycosylated, Polypeptide chain containing 115 amino acids (283-396) and having a molecular mass of 13009 Dalton. ;The BMP-2 is purified by proprietary chromatographic techniques. |
PG LIVER 2 EA* |
59423-2 |
Pel-Freez |
2 EA |
EUR 230.69 |
Individual Reaction Mix 2 |
G065-2 |
ABM |
200 reactions |
EUR 200.4 |
Methylamp DNA Modification Kit |
P-1001 |
EpiGentek |
-
EUR 416.70
-
EUR 149.60
-
EUR 259.60
|
- 80 Reactions
- 40 Reactions
- 80 Reactions
|
FitAmp General Tissue Section DNA Isolation Kit |
P-1003 |
EpiGentek |
-
EUR 754.26
-
EUR 253.00
-
EUR 490.60
|
- 100 Samples
- 50 Samples
- 100 Samples
|
FitAmp Plasma/Serum DNA Isolation Kit |
P-1004 |
EpiGentek |
-
EUR 416.70
-
EUR 149.60
-
EUR 253.00
|
- 100 Samples
- 50 Samples
- 100 Samples
|
TuMinute PCR Clean-Up Kit |
P-1005 |
EpiGentek |
-
EUR 303.60
-
EUR 90.20
-
EUR 171.60
|
- 100 Samples
- 50 Samples
- 100 Samples
|
DNA Concentrator Kit |
P-1006 |
EpiGentek |
-
EUR 303.60
-
EUR 90.20
-
EUR 171.60
|
- 100 Samples
- 50 Samples
- 100 Samples
|
FitAmp Paraffin Tissue Section DNA Isolation Kit |
P-1009 |
EpiGentek |
-
EUR 702.06
-
EUR 239.80
-
EUR 454.30
|
- 100 Samples
- 50 Samples
- 100 Samples
|
Methylamp One-Step DNA Modification Kit |
P-1010 |
EpiGentek |
-
EUR 416.70
-
EUR 148.50
-
EUR 253.00
|
- 80 Samples
- 40 Samples
- 80 Samples
|
Methylamp Universal Methylated DNA Kit |
P-1011 |
EpiGentek |
-
EUR 684.66
-
EUR 292.60
-
EUR 442.20
|
- 20 Modifications
- 10 Modifications
- 20 Modifications
|
FitAmp Circulating DNA Quantification Kit |
P-1012 |
EpiGentek |
-
EUR 595.92
-
EUR 217.80
-
EUR 387.20
|
- 96 Assays
- 48 Assays
- 96 Assays
|
EpiQuik DNA Methyltransferase (DNMT) Activity/Inhibition Assay Kit |
P-3001 |
EpiGentek |
-
EUR 1050.06
-
EUR 424.60
-
EUR 712.80
|
- 96 Assays
- 48 Assays
- 96 Assays
|
EpiQuik Histone Methyltransferase Activity/Inhibition Assay Kit (H3K4) |
P-3002 |
EpiGentek |
-
EUR 1067.46
-
EUR 437.80
-
EUR 724.90
|
- 96 Assays
- 48 Assays
- 96 Assays
|
EpiQuik Histone Methyltransferase Activity/Inhibition Assay Kit (H3K9) |
P-3003 |
EpiGentek |
-
EUR 1067.46
-
EUR 437.80
-
EUR 724.90
|
- 96 Assays
- 48 Assays
- 96 Assays
|
The CMV-NIR status is associated with the incidence of CMV reactivation transplantation which is significantly higher, indicating that the immunity of CMV dysfunctional in prospective lung transplant recipients is associated with an increased risk of viral viral-transplant reactivation.
Keywords: cytomegalovirus; T-cell immunity; solid organ transplant; Virus reactivation.